GLYPICAN-3 PROMOTES HEPATOCELLULAR CARCINOMA PROGRESSION AND METASTASIS BY ACTIVATION OF THE ERK SIGNALING PATHWAY

被引：0
|
作者：
Wu, Y. [1 ]
Liu, H. [1 ]
Weng, H. [2 ]
Zhang, X. [1 ]
Li, P. [1 ]
Fan, C. [1 ]
Li, B. [1 ]
Dong, P. [1 ]
Li, L. [1 ]
Dooley, S. [2 ]
Ding, H. [1 ]
机构：
[1] Capital Med Univ, Beijing Youan Hosp, Dept Gastroenterol & Hepatol, Beijing, Peoples R China
[2] Univ Med Ctr Mannheim, Mol Hepatol, Mannheim, Germany
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30537-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0322
引用
收藏
页码：S429 / S430
页数：2
相关论文
共 50 条
  • [21] Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma
    Allegretta, Mark
    Filmus, Jorge
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2011, 11 (06) : 543 - 548
  • [22] Imaging the expression of glypican-3 in hepatocellular carcinoma by PET
    Zhen Wang
    Yan-Jiang Han
    Shun Huang
    Meng Wang
    Wen-Lan Zhou
    Hong-Sheng Li
    Quan-Shi Wang
    Hu-Bing Wu
    Amino Acids, 2018, 50 : 309 - 320
  • [23] Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
    Li Wang
    Min Yao
    Liu-Hong Pan
    Qi Qian
    Deng-Fu Yao
    Hepatobiliary & Pancreatic Diseases International, 2015, 14 (04) : 361 - 366
  • [24] Glypican-3 and Alphafetoprotein as Diagnostic Tests for Hepatocellular Carcinoma
    Jorge Filmus
    Mariana Capurro
    Molecular Diagnosis, 2004, 8 (4) : 207 - 212
  • [25] Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
    Wang, Li
    Yao, Min
    Pan, Liu-Hong
    Qian, Qi
    Yao, Deng-Fu
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (04) : 361 - 366
  • [26] Zyxin promotes hepatocellular carcinoma progression via the activation of AKT/mTOR signaling pathway
    Cai, Tianying
    Bai, Junjie
    Tan, Peng
    Huang, Zhiwei
    Liu, Chen
    Wu, Ziming
    Cheng, Yonglang
    Li, Tongxi
    Chen, Yifan
    Ruan, Jian
    Gao, Lin
    Du, Yichao
    Fu, Wenguang
    ONCOLOGY RESEARCH, 2023, 31 (05) : 805 - 817
  • [27] Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway
    Wang, Fu
    Xu, Wei-Qi
    Zhang, Wan-Qin
    Xu, Ru-Chen
    Sun, Jia-Lei
    Zhang, Guang-Cong
    Liu, Zhi-Yong
    Qi, Zhuo-Ran
    Dong, Ling
    Weng, Shu-Qiang
    Shen, Xi-Zhong
    Liu, Tao-Tao
    Fang, Ying
    Zhu, Ji-Min
    HEPATOLOGY INTERNATIONAL, 2024, 18 (02) : 636 - 650
  • [28] Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway
    Fu Wang
    Wei-Qi Xu
    Wan-Qin Zhang
    Ru-Chen Xu
    Jia-Lei Sun
    Guang-Cong Zhang
    Zhi-Yong Liu
    Zhuo-Ran Qi
    Ling Dong
    Shu-Qiang Weng
    Xi-Zhong Shen
    Tao-Tao Liu
    Ying Fang
    Ji-Min Zhu
    Hepatology International, 2024, 18 : 636 - 650
  • [29] Elevated TEFM expression promotes growth and metastasis through activation of ROS/ERK signaling in hepatocellular carcinoma
    Lixin Wan
    Yang Wang
    Zijie Zhang
    Jiaxin Wang
    Menglan Niu
    Yuanyuan Wu
    Yating Yang
    Yongxia Dang
    Shuang Hui
    Meng Ni
    Bo Wan
    Dengke Bao
    Cell Death & Disease, 12
  • [30] Elevated TEFM expression promotes growth and metastasis through activation of ROS/ERK signaling in hepatocellular carcinoma
    Wan, Lixin
    Wang, Yang
    Zhang, Zijie
    Wang, Jiaxin
    Niu, Menglan
    Wu, Yuanyuan
    Yang, Yating
    Dang, Yongxia
    Hui, Shuang
    Ni, Meng
    Wan, Bo
    Bao, Dengke
    CELL DEATH & DISEASE, 2021, 12 (04)
12345